NHS Digital FHIR Implementation Guide (Retired - 2.1.50)

This guidance is under active development by NHS Digital and content may be added or updated on a regular basis.

vaccination-covid19-2nd-dose

{
    "id": "551ef667-1402-4c92-ba34-a0bb88b998dc",
    "resourceType": "Immunization",
    "extension":  [
        {
            "url": "https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-VaccinationProcedure",
            "valueCodeableConcept": {
                "coding":  [
                    {
                        "system": "http://snomed.info/sct",
                        "code": "1324691000000104",
                        "display": "Administration of second dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine"
                    }
                ]
            }
        }
    ],
    "identifier":  [
        {
            "system": "https://tools.ietf.org/html/rfc4122",
            "value": "7ec28d82-33bf-4e6d-a8de-91dcbc8d1802"
        }
    ],
    "status": "completed",
    "primarySource": false,
    "reportOrigin": {
        "text": "RR8 - LEEDS TEACHING HOSPITALS NHS TRUST"
    },
    "occurrenceDateTime": "2021-02-23T13:00:08.476+00:00",
    "patient": {
        "reference": "Patient/1953684",
        "type": "Patient",
        "identifier": {
            "system": "https://fhir.nhs.uk/Id/nhs-number",
            "value": "9912003888"
        }
    },
    "vaccineCode": {
        "coding":  [
            {
                "system": "http://snomed.info/sct",
                "code": "39114911000001105",
                "display": "COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)"
            }
        ]
    },
    "manufacturer": {
        "display": "DREAMLAND Pharmaceuticals Ltd"
    },
    "lotNumber": "R04X",
    "protocolApplied":  [
        {
            "doseNumberPositiveInt": 2
        }
    ]
}
<Immunization xmlns="http://hl7.org/fhir">
    <id value="551ef667-1402-4c92-ba34-a0bb88b998dc" />
    <extension url="https://fhir.hl7.org.uk/StructureDefinition/Extension-UKCore-VaccinationProcedure">
        <valueCodeableConcept>
            <coding>
                <system value="http://snomed.info/sct" />
                <code value="1324691000000104" />
                <display value="Administration of second dose of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) vaccine" />
            </coding>
        </valueCodeableConcept>
    </extension>
    <identifier>
        <system value="https://tools.ietf.org/html/rfc4122" />
        <value value="7ec28d82-33bf-4e6d-a8de-91dcbc8d1802" />
    </identifier>
    <status value="completed" />
    <vaccineCode>
        <coding>
            <system value="http://snomed.info/sct" />
            <code value="39114911000001105" />
            <display value="COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials (AstraZeneca UK Ltd)" />
        </coding>
    </vaccineCode>
    <patient>
        <reference value="Patient/1953684" />
        <type value="Patient" />
        <identifier>
            <system value="https://fhir.nhs.uk/Id/nhs-number" />
            <value value="9912003888" />
        </identifier>
    </patient>
    <occurrenceDateTime value="2021-02-23T13:00:08.476+00:00" />
    <primarySource value="false" />
    <reportOrigin>
        <text value="RR8 - LEEDS TEACHING HOSPITALS NHS TRUST" />
    </reportOrigin>
    <manufacturer>
        <display value="DREAMLAND Pharmaceuticals Ltd" />
    </manufacturer>
    <lotNumber value="R04X" />
    <protocolApplied>
        <doseNumberPositiveInt value="2" />
    </protocolApplied>
</Immunization>
Immunization
back to top